However, [CD8+] / [CD4+/CD39+] ratio only differed significantly between tumor tissue and PBMC HNSCC (1.4 ± 1.5 vs. 8.3 ± 11.8; p < 0.005; Figure 1F, right plot). This evidence concerns the gene CD4 and head and neck squamous cell carcinoma.